Literature DB >> 15247263

Poly(ADP-ribosyl)ation as a DNA damage-induced post-translational modification regulating poly(ADP-ribose) polymerase-1-topoisomerase I interaction.

Tetsu M C Yung1, Sachiko Sato, Masahiko S Satoh.   

Abstract

Poly(ADP-ribosyl)ation is a post-translational modification that occurs immediately after exposure of cells to DNA damaging agents. In vivo, 90% of ADP-ribose polymers are attached to the automodification domain of poly(ADP-ribose) polymerase-1 (PARP-1), the main enzyme catalyzing this modification reaction. This enzyme forms complexes with transcription initiation, DNA replication, and DNA repair factors. In most known cases, the interactions occur through the automodification domain. However, functional implications of the automodification reaction on these interactions have not yet been elucidated. In the present study, we created fluorescent protein-tagged PARP-1 to study this enzyme in live cells and focused on the interaction between PARP-1 and topoisomerase I (Topo I), one of the enzymes that interacts with PARP-1 in vitro. Here, we demonstrate that PARP-1 co-localizes with Topo I throughout the cell cycle. Results from bioluminescence resonance energy transfer assays suggest that the co-localization is because of a direct protein-protein interaction. In response to DNA damage, PARP-1 de-localization and a reduction in bioluminescence resonance energy transfer signal because of the automodification reaction are observed, suggesting that the automodification reaction results in the disruption of the interaction between PARP-1 and Topo I. Because Topo I activity has been reported to be promoted by PARP-1, we then investigated the effect of the disruption of this interaction on Topo I activity, and we found that this disruption results in the reduction of Topo I activity. These results suggest that a function for the automodification reaction is to regulate the interaction between PARP-1 and Topo I, and consequently, the Topo I activity, in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247263     DOI: 10.1074/jbc.M402729200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Ring finger protein 146/Iduna is a poly(ADP-ribose) polymer binding and PARsylation dependent E3 ubiquitin ligase.

Authors:  Zhi-dong Zhou; Christine Hui-shan Chan; Zhi-cheng Xiao; Eng-king Tan
Journal:  Cell Adh Migr       Date:  2011 Nov-Dec       Impact factor: 3.405

2.  Double-stranded DNA binding domain of poly(ADP-ribose) polymerase-1 and molecular insight into the regulation of its activity.

Authors:  Orlando Huambachano; Fatima Herrera; Ann Rancourt; Masahiko S Satoh
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

3.  Topoisomerase I and RecQL1 function in Epstein-Barr virus lytic reactivation.

Authors:  Pu Wang; Andrew J Rennekamp; Yan Yuan; Paul M Lieberman
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

4.  Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors.

Authors:  Refael Peleg; Marianna Romzova; Inga Kogan-Zviagin; Ron N Apte; Esther Priel
Journal:  BMC Cancer       Date:  2014-12-03       Impact factor: 4.430

5.  Poly(ADP-ribosyl)ation during chromatin remodeling steps in rat spermiogenesis.

Authors:  Mirella L Meyer-Ficca; Harry Scherthan; Alexander Bürkle; Ralph G Meyer
Journal:  Chromosoma       Date:  2005-04-19       Impact factor: 4.316

6.  Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes.

Authors:  Anand G Patel; Karen S Flatten; Paula A Schneider; Nga T Dai; Jennifer S McDonald; Guy G Poirier; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2011-12-12       Impact factor: 5.157

7.  Activation of poly(ADP)-ribose polymerase (PARP-1) induces release of the pro-inflammatory mediator HMGB1 from the nucleus.

Authors:  Dara Ditsworth; Wei-Xing Zong; Craig B Thompson
Journal:  J Biol Chem       Date:  2007-04-12       Impact factor: 5.157

8.  Therapeutic potential of the poly(ADP-ribose) polymerase inhibitor rucaparib for the treatment of sporadic human ovarian cancer.

Authors:  Maike Ihnen; Christine zu Eulenburg; Teodora Kolarova; Jing Wei Qi; Kanthinh Manivong; Meenal Chalukya; Judy Dering; Lee Anderson; Charles Ginther; Alexandra Meuter; Boris Winterhoff; Siân Jones; Victor E Velculescu; Natarajan Venkatesan; Hong-Mei Rong; Sugandha Dandekar; Nitin Udar; Fritz Jänicke; Gerrit Los; Dennis J Slamon; Gottfried E Konecny
Journal:  Mol Cancer Ther       Date:  2013-05-31       Impact factor: 6.261

9.  Interaction of DNA topoisomerase 1 with DNA intermediates and proteins of base excision repair.

Authors:  N A Lebedeva; N I Rechkunova; K Agama; Y Pommier; O I Lavrik
Journal:  Biochemistry (Mosc)       Date:  2009-11       Impact factor: 2.487

10.  Differential localisation of PARP-1 N-terminal fragment in PARP-1(+/+) and PARP-1(-/-) murine cells.

Authors:  Ida Rachel Rajiah; Jeremy Skepper
Journal:  Mol Cells       Date:  2014-07-31       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.